Author Archives : Birgit Rogell

Home  >>  Author : Birgit Rogell

The Heidelberg Life Sciences Celebrate 10 Years ERC

On März 7, 2017, Posted by , In Allgemein, With No Comments

CellNetworks invites you to an evening of groundbreaking research during which 17 ERC life science grantholders from Heidelberg give insight into the central question of their work. The ERC will celebrate its 10th anniversary this year and is organizing the “ERC Week” from 13-18 March 2017, during which national authorities…

DKFZ: Reprogrammed blood vessels promote cancer spread

On März 6, 2017, Posted by , In Press Releases, With No Comments

Tumor cells use the bloodstream to spread in the body. To reach the blood, they first have to pass the wall of the vessel. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and from the Medical Faculty Mannheim of Heidelberg University have now identified a trick that the…

DKFZ: The New Helmholtz Institute HI-TRON- a collaboration between the DKFZ and the University Medical Center Mainz.

On März 6, 2017, Posted by , In Allgemein, With No Comments

The new Helmholtz Institute HI-TRON is a collaboration of the German Cancer Research Center (DKFZ) in Heidelberg and the Research Institute for Translational Oncology (TRON) at the University Medical Center of the Johannes Gutenberg University in Mainz. The goal of the partnership is to develop effective immunotherapies and to identify…

Heidelberg University: 2 Researchers from Heidelberg University receive ERC-Grant

On Februar 27, 2017, Posted by , In Press Releases, With No Comments

Heidelberg chemist Prof. Dr Michael Mastalerz and the Heidelberg astrophysicist Dr Frank Bigiel are receiving a highly endowed ERC Consolidator Grant of 2 and 1.7 Mio Euro. Prof. Dr. Michael Mastalerz will use the grant to fund a five-year project in which the scientist and his team will be working…

TU Kaiserslautern: TU Kaiserslautern successful in start-up support

On Februar 27, 2017, Posted by , In Allgemein, With No Comments

The Technische Universität (TU) Kaiserslautern improved its position in the german-wide University ranking of start-up support. The TU Kaiserslautern has the third place in the catagory „middle size universities with less than 15.000 students. Read full press release here

EMBL/GSK: GSK and EMBL form a new strategic collaboration to enhance understanding of disease and drug mechanisms

On Februar 17, 2017, Posted by , In Press Releases, With No Comments

EMBL and GSK have signed a collaboration agreement to leverage the skills of both organisations to enhance understanding of disease and drug mechanisms and advance early drug discovery. EMBL and GSK will jointly develop and apply cutting edge technologies that will allow the comprehensive characterisation of how a potential new medicine…

Roche: Roche enters a new era in haematology testing, with the launch of the new cobas m 511 analyser

On Februar 16, 2017, Posted by , In Press Releases, With No Comments

Roche announced today that its new, dedicated haematology testing solution, the cobas m 511 integrated haematology analyser, is now available for countries accepting the CE Mark*. This launch marks the entry for Roche Diagnostics in the haematology market, with a Roche developed system. Currently, haematology testing requires a larger blood…

Boehringer Ingelheim: Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments

On Februar 16, 2017, Posted by , In Press Releases, With No Comments

Ingelheim, Germany, February 15, 2017 – Boehringer Ingelheim today announced a collaboration with Weill Cornell Medicine to identify new treatment approaches for chronic obstructive pulmonary disease (COPD) in order to develop novel treatments that could possibly halt or even reverse the progression of the disease process. The new, three-year collaboration…

DKFZ/DZIF: Epstein-Barr virus and cancer: new tricks from an old dog

On Februar 14, 2017, Posted by , In Press Releases, With No Comments

Scientists at the German Cancer Research Center (DKFZ), at the German Center for Infection Research (DZIF), and at the French National Institute of Health and Medical Research (Inserm) have now discovered that a component of the Epstein-Barr virus infectious particle promotes carcinogenesis. This viral protein interferes with cell division and…

AbbVie: AbbVie Germany leads IMI-Projekt on Alzheimer’s Disease research

On Februar 14, 2017, Posted by , In Press Releases, With No Comments

To boost the development of new medicines for AD, a major new European-wide project has now been launched to investigate an area of AD research which has previously received little attention. The ADAPTED (Alzheimer’s Disease Apolipoprotein Pathology for Treatment Elucidation and Development) project focusses on the APOE gene which is…